Market Cap 43.85M
Revenue (ttm) 410,000.00
Net Income (ttm) -7.66M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -1,868.29%
Debt to Equity Ratio 0.04
Volume 919,500
Avg Vol 1,884,516
Day's Range N/A - N/A
Shares Out 36.54M
Stochastic %K 6%
Beta 1.71
Analysts Strong Sell
Price Target $18.00

Latest News on BDRX

Result of General Meeting

Nov 22, 2024, 8:30 AM EST - 4 months ago

Result of General Meeting


Notice of General Meeting

Nov 7, 2024, 4:30 PM EST - 5 months ago

Notice of General Meeting


Biodexa Announces Successful Appeal of Nasdaq Delisting

Oct 15, 2024, 4:15 PM EDT - 6 months ago

Biodexa Announces Successful Appeal of Nasdaq Delisting


Interim results for the six months ended June 30, 2024

Sep 26, 2024, 8:30 AM EDT - 6 months ago

Interim results for the six months ended June 30, 2024


ADR Ratio Change

Sep 19, 2024, 4:30 PM EDT - 6 months ago

ADR Ratio Change


Receipt of Nasdaq Delisting Determination - Plans to Appeal

Aug 30, 2024, 4:30 PM EDT - 7 months ago

Receipt of Nasdaq Delisting Determination - Plans to Appeal


Preliminary Results for the Year Ended 31 December 2023

Apr 19, 2024, 8:00 AM EDT - 1 year ago

Preliminary Results for the Year Ended 31 December 2023